Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H ( (HK:6990) ) just unveiled an announcement.
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. announced the closure of its register of members from December 24 to December 31, 2025, to determine shareholders eligible to attend and vote at the extraordinary general meeting on December 31, 2025. This move is a standard procedure to ensure that only registered shareholders can participate in the decision-making process, potentially impacting shareholder engagement and governance.
The most recent analyst rating on (HK:6990) stock is a Buy with a HK$545.00 price target. To see the full list of analyst forecasts on Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H stock, see the HK:6990 Stock Forecast page.
More about Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the biopharmaceutical industry. The company focuses on developing and providing biopharmaceutical products and services.
Average Trading Volume: 659,777
Technical Sentiment Signal: Buy
Current Market Cap: HK$104B
See more data about 6990 stock on TipRanks’ Stock Analysis page.